Inicio › Cáncer de seno › Connecticut › Bridgeport
Ensayos clínicos de Cáncer de seno en Bridgeport, CT
21 estudios para Cáncer de seno buscan participantes en centros de Bridgeport y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Stony Brook University Medical Center, Stony Brook · A 18 mi de distancia
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
ReclutandoFase 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · A 18 mi de distancia
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
ReclutandoFase 3
- Research Site, Stony Brook · A 18 mi de distancia
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
ReclutandoFase 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · A 4 mi de distancia
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · A 5 mi de distancia
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Reclutando
- Stony Brook Cancer Center, Stony Brook · A 18 mi de distancia
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
ReclutandoFase 1/2
- Stony Brook University Hospital, Stony Brook · A 18 mi de distancia
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ReclutandoFase 3
- Stony Brook University Medical Center, Stony Brook · A 18 mi de distancia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ReclutandoFase 3
- Stony Brook University Cancer Center, Stony Brook · A 18 mi de distancia
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
ReclutandoFase 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · A 19 mi de distancia
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · A 19 mi de distancia
- New York Cancers & Blood Specialists, Port Jefferson Station · A 19 mi de distancia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ReclutandoFase 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · A 4 mi de distancia
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · A 5 mi de distancia
- y 1 más
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
ReclutandoFase 2
- Stony Brook Cancer Center, Stony Brook · A 18 mi de distancia
ATEMPT 2.0: Adjuvant T-DM1 vs TH
ReclutandoFase 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · A 4 mi de distancia
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · A 5 mi de distancia
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
ReclutandoFase 1
- New York Cancer and Blood Specialists, Port Jefferson Station · A 19 mi de distancia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ReclutandoFase 3
- Stony Brook University Cancer Center, Stony Brook · A 18 mi de distancia
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
ReclutandoFase 3
- Smilow Cancer Hospital - Fairfield, Fairfield · A 5 mi de distancia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ReclutandoFase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · A 4 mi de distancia
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · A 5 mi de distancia
- Stony Brook University Medical Center, Stony Brook · A 18 mi de distancia
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
ReclutandoEstudio observacional
- Stony Brook Medicine, Stony Brook · A 18 mi de distancia
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
ReclutandoFase 1 temprana
- Stony Brook Breast Center, Stony Brook · A 18 mi de distancia
Definitive Radiation Therapy for Inoperable Breast Cancer
Reclutando
- Stony Brook University Cancer Center, Stony Brook · A 18 mi de distancia
Definitive Radiation for High-Risk Spine Metastases
ReclutandoFase 2
- Stony Brook University Hospital, Stony Brook · A 18 mi de distancia
CtDNA Based MRD Testing for NAC Monitoring in TNBC
ReclutandoEstudio observacional
- Stony Brook University Cancer Center, Stony Brook · A 18 mi de distancia
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Bridgeport
- Cáncer de pulmón de células no pequeñas14 estudios
- Cáncer de pulmón13 estudios
- Leucemia mielógena aguda12 estudios
- Enfermedad cardiovascular9 estudios
- Cáncer (todos los tipos)8 estudios
- Carcinoma de células escamosas de cabeza y cuello8 estudios
- Cáncer metastásico7 estudios
- Fallo cardíaco7 estudios
- Aneurisma cerebral6 estudios
- Mieloma múltiple6 estudios
- Cáncer de próstata6 estudios
- Cáncer de ovario5 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.